- The disease
- Medical imaging generates large volumes of data across radiology, cardiology, and other clinical disciplines. Health systems need to store, retrieve, and share these images regardless of the equipment manufacturer that produced them. A vendor-neutral archive (VNA) is a storage platform that accepts images in standard formats from any imaging device or system, making images accessible across different sites and applications. Managing this data efficiently is a core operational requirement for hospitals and health networks.
- What the asset is trying to do
- Visage 7 Open Archive is a VNA software platform developed by Pro Medicus Limited (ASX: PME). It is designed to consolidate medical images from multiple source systems into a single repository using vendor-agnostic standards, primarily the DICOM (Digital Imaging and Communications in Medicine) format. The platform is integrated with Pro Medicus's Visage 7 viewing software, allowing image storage and retrieval to operate within the same product environment. This integrated architecture differs from standalone VNA products that require a separate viewer from a different vendor.
- What the trial is measuring, and why it matters
- As a commercially deployed software product, Visage 7 Open Archive is not subject to a clinical trial with formal endpoints. Performance is assessed by health system customers through operational metrics such as system uptime, retrieval speed, integration with existing hospital information systems, and total cost of ownership. Contract renewals and new contract signings serve as observable commercial indicators of customer satisfaction and platform adoption.
- Efficacy benchmarks in this setting
- The VNA market does not have clinical efficacy benchmarks in the way drug trials do; there are no published response rates or survival figures applicable to this category. Market research firms including KLAS Research publish annual vendor performance rankings for VNA and enterprise imaging platforms, which health system procurement teams use as reference points. specific KLAS scores or comparable third-party performance rankings for Visage 7 Open Archive and named competitors.
- Commercial context
- Visage 7 Open Archive is a commercially approved and deployed product, not a pipeline asset under regulatory review. Pro Medicus disclosed a 5-year, A$16 million contract renewal with Ohio State University (OSU) (per ASX announcement, 2026-06-03), a 5-year, A$28 million contract renewal with Allegheny Health Network (per ASX announcement, 2026-05-31), and a 7-year, A$16 million contract with TidalHealth (per ASX announcement, 2026-05-31). Pro Medicus also disclosed a binding Heads of Agreement with Echo IQ covering a finance facility and reseller agreement (per ASX announcement, 2026-06-24). Visage 7 is described as Pro Medicus's primary commercial platform across its enterprise imaging portfolio.